Stoxx Europe 50
4.522,36
PKT
+26,80
PKT
+0,60
%
Werbung
Analysen zu Stoxx Europe 50-Werten
Datum | Rating | Analyst | |
---|---|---|---|
04.02.25 | Mercedes-Benz Group (ex Daimler) Neutral | Goldman Sachs Group Inc. | |
03.02.25 | Mercedes-Benz Group (ex Daimler) Market-Perform | Bernstein Research | |
03.02.25 | Novo Nordisk Buy | UBS AG | |
03.02.25 | AB InBev SA-NV (Anheuser-Busch InBev) Overweight | JP Morgan Chase & Co. | |
03.02.25 | Diageo Neutral | JP Morgan Chase & Co. | |
03.02.25 | Roche Underweight | JP Morgan Chase & Co. | |
03.02.25 | UniCredit Overweight | JP Morgan Chase & Co. | |
03.02.25 | Diageo Buy | Jefferies & Company Inc. | |
03.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
03.02.25 | Airbus Overweight | JP Morgan Chase & Co. | |
03.02.25 | Mercedes-Benz Group (ex Daimler) Outperform | RBC Capital Markets | |
03.02.25 | HSBC Sector Perform | RBC Capital Markets | |
03.02.25 | Enel Buy | Goldman Sachs Group Inc. | |
03.02.25 | Novartis Hold | Deutsche Bank AG | |
03.02.25 | Novartis Kaufen | DZ BANK | |
03.02.25 | LOréal Hold | Jefferies & Company Inc. | |
03.02.25 | Unilever Sell | UBS AG | |
03.02.25 | LOréal Neutral | UBS AG | |
03.02.25 | Nestlé Neutral | UBS AG | |
03.02.25 | Novartis Buy | UBS AG | |
03.02.25 | Sanofi Buy | UBS AG | |
03.02.25 | Airbus Neutral | UBS AG | |
03.02.25 | HSBC Buy | Goldman Sachs Group Inc. | |
03.02.25 | HSBC Hold | Deutsche Bank AG | |
03.02.25 | AB InBev SA-NV (Anheuser-Busch InBev) Buy | Jefferies & Company Inc. | |
03.02.25 | Mercedes-Benz Group (ex Daimler) Hold | Jefferies & Company Inc. | |
31.01.25 | Sanofi Kaufen | DZ BANK | |
31.01.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
31.01.25 | LVMH Moet Hennessy Louis Vuitton Outperform | RBC Capital Markets | |
31.01.25 | Roche Sell | Deutsche Bank AG | |
31.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
31.01.25 | Novartis Buy | UBS AG | |
31.01.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
31.01.25 | Roche Neutral | UBS AG | |
31.01.25 | LOréal Neutral | UBS AG | |
31.01.25 | Sanofi Buy | UBS AG | |
31.01.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
31.01.25 | Intesa Sanpaolo Overweight | JP Morgan Chase & Co. | |
31.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
31.01.25 | Novartis Outperform | Bernstein Research |